{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T23:28:19Z","timestamp":1748906899547},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s11684-019-0680-1","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T13:20:26Z","timestamp":1548940826000},"page":"94-103","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma"],"prefix":"10.1007","volume":"13","author":[{"given":"Yiwen","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binshen","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengpeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengde","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"issue":"8","key":"680_CR1","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"K Ekstr\u00f6m Smedby","year":"2008","unstructured":"Ekstr\u00f6m Smedby K, Vajdic CM, Falster M, Engels EA, Mart\u00ednez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori Costantini A, Bracci PM, Holly EA, Willett E, Spinelli JJ, La Vecchia C, Zheng T, Becker N, De Sanjos\u00e9 S, Chiu BC, Dal Maso L, Cocco P, Maynadi\u00e9 M, Foretova L, Staines A, Brennan P, Davis S, Severson R, Cerhan JR, Breen EC, Birmann B, Grulich AE, Cozen W. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111(8): 4029\u20134038","journal-title":"Blood"},{"issue":"3","key":"680_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstr\u00f6m C, Klareskog L. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006; 54(3): 692\u2013701","journal-title":"Arthritis Rheum"},{"key":"680_CR3","first-page":"502","volume":"17","author":"A Bilici","year":"2012","unstructured":"Bilici A, Yapici HS, Ercan S, Seker M, Ustaalioglu BB, Salman T, Orcun A, Gumus M. The prevalence and significance of autoantibodies in patients with non-Hodgkin\u2019s lymphoma: are they correlated with clinicopathological features? J BUON 2012;17: 502\u2013507","journal-title":"J BUON"},{"issue":"3","key":"680_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","volume":"41","author":"A Solans-Laqu\u00e9 RL\u00f3pez-Hernandez","year":"2011","unstructured":"Solans-Laqu\u00e9 RL\u00f3pez-Hernandez A, Bosch-Gil JA, Palacios A, Campillo M, Vilardell-Tarres M. Risk, predictors, and clinical characteristics of lymphoma development in primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum 2011; 41(3): 415\u2013423","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"680_CR5","first-page":"83","volume":"102","author":"E Sabattini","year":"2010","unstructured":"Sabattini E, Bacci F, Sagramoso C, Pileri SA. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Pathologica 2010; 102(3): 83\u201387","journal-title":"Pathologica"},{"issue":"3","key":"680_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1136\/annrheumdis-2013-204575","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, van der Heijde D, Winthrop K, Landew\u00e9 R. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 2014; 73(3): 529\u2013535","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"680_CR7","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, S\u00e1nchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K,Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64(8): 2677\u20132686","journal-title":"Arthritis Rheum"},{"key":"680_CR8","volume-title":"Arthritis Rheumatol","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X; International Sj\u00f6gren\u2019s Syndrome Criteria Working Group. 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sj\u00f6gren\u2019s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 2017;69 (1):35\u201345"},{"issue":"12","key":"680_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10067-008-0944-7","volume":"27","author":"IF Horvath","year":"2008","unstructured":"Horvath IF, Szodoray P, Zeher M. Primary Sj\u00f6gren\u2019s syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 2008; 27(12): 1479\u20131483","journal-title":"Clin Rheumatol"},{"issue":"10","key":"680_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1253\/jcj.44.808","volume":"44","author":"N Watanabe","year":"1980","unstructured":"Watanabe N, Arimura A, Kobayashi M, Oshima M. ASO, ASK and ADNase-B values rheumatic fever, rheumatic heart disease and other infections by hemolytic streptococcus: Proceedings of the IV Conference on Prevention for Rheumatic Fever and Rheumatic Heart Disease, January 1979, Kyoto. Jpn Circ J 1980; 44(10): 808\u2013809","journal-title":"Jpn Circ J"},{"issue":"3","key":"680_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.clinbiochem.2014.11.008","volume":"48","author":"K Ohyama","year":"2015","unstructured":"Ohyama K, Baba M, Tamai M, Aibara N, Ichinose K, Kishikawa N, Kawakami A, Kuroda N. Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases. Clin Biochem 2015; 48(3): 181\u2013185","journal-title":"Clin Biochem"},{"issue":"2","key":"680_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1365-2249.1990.tb05436.x","volume":"82","author":"H Tsukamoto","year":"1990","unstructured":"Tsukamoto H, Ueda A, Nagasawa K, Tada Y, Niho Y. Increased production of the third component of complement (C3) by monocytes from patients with systemic lupus erythematosus. Clin Exp Immunol 1990; 82(2): 257\u2013261","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"680_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V;International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25(5): 579\u2013586","journal-title":"J Clin Oncol"},{"key":"680_CR14","volume-title":"J Clin Immunol","author":"J Candido","year":"2013","unstructured":"Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol 2013;33( Suppl 1):S79\u2013S84"},{"issue":"9","key":"680_CR15","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3324\/haematol.2009.007005","volume":"94","author":"U Vitolo","year":"2009","unstructured":"Vitolo U, Chiappella A, Angelucci E, Rossi G, Liberati AM, Cabras MG, Botto B, Ciccone G, Gaidano G, Falchi L, Freilone R, Novero D, Orsucci L, Pavone V, Pogliani E, Rota-Scalabrini D, Salvi F, Tonso A, Tucci A, Levis A;Gruppo Italiano Multiregionale e Leucemie (GIMURELL). Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study. Haematologica 2009; 94(9): 1250\u20131258","journal-title":"Haematologica"},{"issue":"4","key":"680_CR16","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cam4.241","volume":"3","author":"ET Sayegh","year":"2014","unstructured":"Sayegh ET, Bloch O, Parsa AT. Complement anaphylatoxins as immune regulators in cancer. Cancer Med 2014; 3(4): 747\u2013758","journal-title":"Cancer Med"},{"issue":"10","key":"680_CR17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1093\/annonc\/mdu365","volume":"25","author":"M Fallah","year":"2014","unstructured":"Fallah M, Liu X, Ji J, F\u00f6rsti A, Sundquist K, Hemminki K. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study. Ann Oncol 2014; 25(10): 2025\u20132030","journal-title":"Ann Oncol"},{"issue":"4","key":"680_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jaut.2012.09.002","volume":"39","author":"O Ngalamika","year":"2012","unstructured":"Ngalamika O, Zhang Y, Yin H, Zhao M, Gershwin ME, Lu Q. Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review. J Autoimmun 2012; 39(4): 451\u2013465","journal-title":"J Autoimmun"},{"issue":"10","key":"680_CR19","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012; 11(10): 754\u2013765","journal-title":"Autoimmun Rev"},{"issue":"6937","key":"680_CR20","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423(6937): 356\u2013361","journal-title":"Nature"},{"issue":"4","key":"680_CR21","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11926-002-0045-6","volume":"4","author":"S Bernatsky","year":"2002","unstructured":"Bernatsky S, Clarke A, Ramsey-Goldman R. Malignancy and systemic lupus erythematosus. Curr Rheumatol Rep 2002; 4(4): 351\u2013358","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"680_CR22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-857X(21)00314-8","volume":"18","author":"RI Fox","year":"1992","unstructured":"Fox RI, Kang HI. Pathogenesis of Sjogren\u2019s syndrome. Rheum Dis Clin North Am 1992; 18(3): 517\u2013538","journal-title":"Rheum Dis Clin North Am"},{"issue":"14","key":"680_CR23","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1200\/JCO.2010.33.3252","volume":"29","author":"H Nogai","year":"2011","unstructured":"Nogai H, D\u00f6rken B, Lenz G. Pathogenesis of non-Hodgkin\u2019s lymphoma. J Clin Oncol 2011; 29(14): 1803\u20131811","journal-title":"J Clin Oncol"},{"issue":"10","key":"680_CR24","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1182\/blood.V96.10.3569","volume":"96","author":"SA Riemersma","year":"2000","unstructured":"Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, Kluin PM. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood 2000; 96(10): 3569\u20133577","journal-title":"Blood"},{"issue":"1","key":"680_CR25","first-page":"60","volume":"17","author":"E Lech-Maranda","year":"2006","unstructured":"Lech-Maranda E, Bienvenu J, Michallet AS, Houot R, Robak T, Coiffier B, Salles G. Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma. Eur Cytokine Netw 2006; 17(1): 60\u201366","journal-title":"Eur Cytokine Netw"},{"issue":"11","key":"680_CR26","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","volume":"103","author":"LM Rimsza","year":"2004","unstructured":"Rimsza LM, Roberts RA, Miller TP, Unger JM, LeBlanc M, Braziel RM, Weisenberger DD, Chan WC, Muller-Hermelink HK, Jaffe ES, Gascoyne RD, Campo E, Fuchs DA, Spier CM, Fisher RI, Delabie J, Rosenwald A, Staudt LM, Grogan TM. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 2004; 103(11): 4251\u20134258","journal-title":"Blood"},{"issue":"3","key":"680_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1093\/jnci\/djr516","volume":"104","author":"KY Urayama","year":"2012","unstructured":"Urayama KY, Jarrett RF, Hjalgrim H, Diepstra A, Kamatani Y, Chabrier A, Gaborieau V, Boland A, Nieters A, Becker N, Foretova L, Benavente Y, Maynadi\u00e9 M, Staines A, Shield L, Lake A, Montgomery D, Taylor M, Smedby KE, Amini RM, Adami HO, Glimelius B, Feenstra B, Nolte IM, Visser L, van Imhoff GW, Lightfoot T, Cocco P, Kiemeney L, Vermeulen SH, Holcatova I, Vatten L, Macfarlane GJ, Thomson P, Conway DI, Benhamou S, Agudo A, Healy CM, Overvad K, Tj\u00f8nneland A, Melin B, Canzian F, Khaw KT, Travis RC, Peeters PH, Gonz\u00e1lez CA, Quir\u00f3s JR, S\u00e1nchez MJ, Huerta JM, Ardanaz E, Dorronsoro M, Clavel-Chapelon F, Bueno-de-Mesquita HB, Riboli E, Roman E, Boffetta P, de Sanjos\u00e9 S, Zelenika D, Melbye M, van den Berg A, Lathrop M, Brennan P, McKay JD. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst 2012; 104(3): 240\u2013253","journal-title":"J Natl Cancer Inst"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11684-019-0680-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-019-0680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-019-0680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T05:35:41Z","timestamp":1662874541000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11684-019-0680-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s11684-019-0680-1","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}